Medicinal Chemistry, SAR, and Molecular Insights Into 2,4‐Thiazolidinediones as Antidiabetic Agents (2020–2025)
Sign Up to like & getrecommendations! Published in 2025 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.70102
Abstract: The thiazolidinedione (TZD) scaffold has long been recognized for its pharmacological versatility, particularly in the treatment of metabolic and inflammatory disorders. Among its derivatives, 2,4‐thiazolidinediones (2,4‐TZDs) have emerged as a prominent class of antidiabetic agents… read more here.
Keywords: chemistry; 2025 medicinal; chemistry sar; antidiabetic agents ... See more keywords